knowlabs.co (USBC) - יתרות מזומנים למניה

USBC Inc is currently in the R&D stage without revenue, which increases unit costs. The cash per share forecast demonstrates current liquidity, where the indicator level stands at 0.01. This is driven by strict FDA oversight and biosensor patents, as well as the outsourcing of manufacturing and cloud computing to third-party contractors to optimize resources.
פילוחים אנליטיים של חברת knowlabs.co (USBC)

This indicator reflects the company's net liquidity minus short-term debt, allowing investors to filter out speculative noise from a genuine strengthening of financial stability. By analyzing fluctuations in cash per share, one can assess the ability of USBC Inc (USBC) to fund a costly staff of sensor developers and opticians without compromising operational stability due to high personnel compensation costs.